{
    "organizations": [],
    "uuid": "15b0d77d7cec6137250d1e36c9b6a084715847dc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novus-therapeutics-reports-quarter/brief-novus-therapeutics-reports-quarterly-loss-per-share-of-0-36-idUSFWN1SI0N2",
    "ord_in_thread": 0,
    "title": "BRIEF-Novus Therapeutics Reports Quarterly Loss Per Share Of $0.36",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 11 (Reuters) - Novus Therapeutics Inc:\n* QUARTERLY LOSS PER SHARE $0.36 * NOVUS THERAPEUTICS SAYS HAD $22.5 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31 - SEC FILING Source text: ( bit.ly/2rza3AD ) Further company coverage:\n ",
    "published": "2018-05-11T18:20:00.000+03:00",
    "crawled": "2018-05-12T17:30:21.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "novus",
        "therapeutic",
        "inc",
        "quarterly",
        "loss",
        "per",
        "share",
        "novus",
        "therapeutic",
        "say",
        "million",
        "cash",
        "cash",
        "equivalent",
        "march",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}